Instanyl: intranasal fentanyl for treating breakthrough pain

Instanyl is an intranasal formulation of fentanyl licensed for breakthrough pain management in chronic cancer pain. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse effects and Dr Giovambattista Zeppetella discusses its place in the management of breakthrough pain. Copyright © 2010 Wiley Interface Ltd